Tech Company Financing Transactions
Otolith Labs Funding Round
On 9/7/2022, Otolith Labs raised $20 million in Series A funding from Morningside Ventures and private investors.
Transaction Overview
Company Name
Announced On
9/7/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Morningside Ventures (Anthony Aiudi)
Proceeds Purpose
The proceeds will be used to support the company's ongoing clinical programs, anticipated FDA approval and first commercial launch of a prescription wearable device using its noninvasive Vestibular System Masking (nVSM) technology for the treatment of chronic vertigo.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1250 Connecticut Ave. NW 700
Washington, DC 20036
USA
Washington, DC 20036
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Otolith Labs is pioneering the first medical wearable for the treatment of vertigo, a symptom experienced by more than 15 million Americans. Otolith's patented non-invasive head-worn technology uses precisely tuned vibrations to interact with the motion sensors in the inner ear, mitigating the symptoms of vertigo and motion sickness.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sam Owen
Chief Operating Officer
Jack Daggitt
Chief Scientific Officer
Didier Depireux
VP - Bus. Development
Thomas Hardart
VP - Product Management
Jon Akers
Browse more venture capital transactions:
Prev: 9/7/2022: Flair venture capital transaction
Next: 9/7/2022: PWCC Marketplace venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs